Patents by Inventor Catherine Soulet

Catherine Soulet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MELANOCORTIN RECEPTOR ANTAGONIST COMPOUNDS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS
    Publication number: 20150329522
    Abstract: The present invention relates to novel melanocortin receptor antagonist compounds corresponding to the general formula (I) below: to compositions containing them, to the process for preparing them and to their use in pharmaceutical or cosmetic compositions.
    Type: Application
    Filed: January 30, 2015
    Publication date: November 19, 2015
    Inventors: Claire BOUIX-PETER, Isabelle CARLAVAN, Catherine SOULET, Véronique PARNET, Johannes VOEGEL
  • Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
    Patent number: 8962846
    Abstract: Melanocortin receptor antagonist compounds, processes for preparing them and uses thereof in human medicine and cosmetics are described. Melanocortin receptor antagonist compounds corresponding to the general formula (I): compositions containing them, and processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: February 24, 2015
    Assignee: Galderma Research & Development
    Inventors: Claire Bouix-Peter, Isabelle Carlavan, Catherine Soulet, Veronique Parnet, Johannes Voegel
  • Ligands that modulate RAR receptors
    Patent number: 8470871
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: June 25, 2013
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • NOVEL LIGANDS THAT MODULATE RAR RECEPTORS
    Publication number: 20120258996
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: June 19, 2012
    Publication date: October 11, 2012
    Applicant: Galderma Research & Development
    Inventors: Thibaud BIADATTI, Laurence DUMAIS, Catherine SOULET, Sandrine TALANO, Sebastien DAVER
  • Ligands that modulate RAR receptors
    Patent number: 8227507
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: July 24, 2012
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • MELANOCORTIN RECEPTOR ANTAGONIST COMPOUNDS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS
    Publication number: 20110281913
    Abstract: Melanocortin receptor antagonist compounds, processes for preparing them and uses thereof in human medicine and cosmetics are described. Melanocortin receptor antagonist compounds corresponding to the general formula (I): compositions containing them, and processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 17, 2011
    Applicant: Galderma Research & Development
    Inventors: Claire Bouix-Peter, Isabelle Carlavan, Catherine Soulet, Veronique Parnet, Johannes Voegel
  • NOVEL LIGANDS THAT MODULATE RAR RECEPTORS
    Publication number: 20100292296
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: July 23, 2010
    Publication date: November 18, 2010
    Applicant: Galderma Research & Development
    Inventors: Thibaud BIADATTI, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof
    Patent number: 7807708
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: October 5, 2010
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • Novel ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof
    Publication number: 20080015246
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: June 25, 2007
    Publication date: January 17, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver